Eisai, Biogen say FDA grants priority review for Alzheimer's drug Lecanemab https://t.co/Ym1X51nVBV pic.twitter.com/9NTKMbzI1r— Reuters (@Reuters) March 6, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


